Balwani Guilty! Sentencing Is Next for Theranos Execs

By Robert Michel | From the Volume XXIX, No. 10 – July 18, 2022 Issue

CEO SUMMARY: The trial of former Theranos President and Chief Operating Officer Ramesh “Sunny” Balwani ended with convictions by a jury on 12 counts of wire fraud and conspiracy. Now all eyes are looking ahead to the sentencing of Balwani and Elizabeth Holmes, the founder and fo…

Read More

---

New Percentage-Based Commissions Ruling

By Robert Michel | From the Volume XXIX, No. 10 – July 18, 2022 Issue

CEO SUMMARY: In denying a motion to dismiss certain charges against a clinical laboratory owner, a federal court in California has declared that the Eliminating Kickbacks in Recovery Act (EKRA) of 2018 applies to payments for marketing to physicians and other referral sources. This …

Read More

---

Halfway Through 2022, More Changes Come at Labs

By R. Lewis Dark | From the Volume XXIX, No. 8 – June 6, 2022 Issue

APPROACHING THE MIDWAY MARK OF 2022, some clinical laboratory directors and pathologists might feel like they’ve already experienced enough changes to last the whole year.  For example, since the start of 2022, we’ve seen SARS-CoV-2 testing surges co…

Read More

---

DOJ Charges Execs over Alleged Lab Kickbacks to Obtain Restitution

By Robert Michel | From the Volume XXIX, No. 8 – June 6, 2022 Issue

CEO SUMMARY: Multiple executives and sales representatives at True Health Diagnostics and Boston Heart Diagnostics have been named as defendants in a civil suit filed by the U.S. Department of Justice. The complaint centers on alleged kickbacks in return for clinical laboratory test…

Read More

---

Labs Can Expect COVID-19 Lab Testing Audits and Federal Investigations

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

This is an excerpt of a 2,081-word article in the May 16, 2022 issue of  THE DARK REPORT. The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Billions of federal dollars were paid out for needed SARS-CoV-2 testing during the pandemic. Now, even th…

Read More

---

Labs Can Expect COVID-19 Test Audits, Investigations

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

  CEO SUMMARY: Billions of federal …

Read More

---

DOJ: EKRA Governs Lab Sales and Marketing Commissions

By Robert Michel | From the Volume XXIX, No. 6 – April 25, 2022 Issue

BY FILING A MOTION IN A U.S. DISTRICT COURT RECENTLY, officials from the federal Department of Justice (DOJ) took steps to oppose an earlier ruling by a federal judge in Hawaii dealing with the way the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) governs how percentage-based commission…

Read More

---

In Civil Suit, DOJ Seeks Triple Damages for Lab Test Fraud

By Robert Michel | From the Volume XXIX, No. 6 – April 25, 2022 Issue

CERTAIN CLINICAL LABORATORY EXECUTIVES AND LAB SALES PROFESSIONALS may soon be made to pay where it hurts most—in their wallets.  The U.S. Department of Justice (DOJ) announced on April 4 that it had joined a civil complaint against 18 defendant…

Read More

---

Federal Healthcare Fraud Enforcement Turns to Emerging Areas

By Robert Michel | From the Volume XXIX, No. 5 – April 4, 2022 Issue

CEO SUMMARY: Healthcare compliance attorneys say the Department of Justice (DOJ) is turning its focus to fraudulent activity related to COVID-19 testing. But that’s not the only area attracting greater scrutiny by the DOJ. Fraud stemming from opioid treatment has snared clinical l…

Read More

---

Another 10 Doctors Settle Laboratory Kickback Cases, Pay Back $1.68m

By Robert Michel | From the Volume XXIX, No. 5 – April 4, 2022 Issue

FALLOUT CONTINUES FROM A LARGE LABORATORY KICKBACK INVESTIGATION in Texas, as another 10 physicians and one healthcare executive agreed to settle with the government and pay back $1.68 million.  Clinical lab sales teams throughout the United States will …

Read More

---